AI & Healthcare News — 2026-10-21 (Wed)

Overview

In the area of mental health, measures have been taken to measure the impact of AI, including public opinion polls and the establishment of review organizations. In the area of physical health, the development of wearable devices and medical examination AI continued. In terms of mechanisms, the biggest move is that the US FDA and UK MHRA have proceeded with consideration of the regulatory framework for generative AI.

Mental health

- It was reported that a new organization will be established to study the impact of AI on mental health (NPR/US). The scope and scale of the study cannot be confirmed from the headline. - AI appeared as an item in a US public opinion poll for the first time, and concerns were expressed about it as a subject of anxiety along with politics and the economy (Korea Economic Daily). There is no mention of the entity conducting the survey or the sample size. - A study was introduced that analyzed the relationship between students' career confidence, AI skills, and job anxiety (Devdiscourse). The research design and target scale are unclear from the headline. - The complexity of AI scribing (recording support) in mental health examinations, including how to handle unspoken information, was discussed (AusDoc/Australia). No description of measurement content or scale. - AI entry into infusion therapy and intravenous access was reported along with an influx of venture capital (Yahoo Finance). Although this is an area that aims to reduce the burden on clinical sites, there are no numerical results in the headlines.

Exercise/physical activity

- How humans can maintain control with wearable AI was presented in a World Economic Forum (WEF) paper. Mainly focuses on organizing issues regarding systems and operations. - A discussion was raised about whether AI can replace human hands in physical therapy and massage (MedicalResearch.com). The level of evidence such as comparative trials is unclear from the headline. - ECG AI 510(k) (premarket notification to the US FDA) and China's smart ring were reported as industry news (MobiHealthNews). Details of the subject and status of the notification are not listed in the heading.

sleep

No relevant information (there is a headline related to smart rings, but no reference to sleep is specified in the headline).

Nutrition/Meals

- Japan's MURO launches recipe service using AI x precision nutrition (PR TIMES). It is characterized by proposals tailored to the individual's condition, but the content and scale of the effectiveness verification cannot be confirmed from the headline.

Prevention/Medical checkup

- AI that predicts the survival rate of cancer patients from images was reported as a "breakthrough" (Vietnam.vn). The target population and study stage (laboratory or observational study) are unclear from the headline. - Development of 'better predictors' of hypertension risk featured in morning medical bulletin (Medical Economics). No description of target population or accuracy.

Self-management of chronic diseases

- An interview with Jean Bourbeau, MD about AI and new technologies in COPD care has been published (HCPLive). The content is based on the opinions of experts. - AI detects the risk of functional decline in heart failure patients (Cardiovascular Business). No mention of research design or number of facilities. - AI identifies four distinct phenotypes in adult asthma (EMJ). It is unclear from the headline whether this is an observational study or an intervention study. - AI model predicts that antimicrobial resistance of Salmonella in China's food chain will increase until 2050 (King's College London/UK). Please note that this is a predictive model and not an actual measurement.

Elderly people/nursing care

- Concerning AI that will reshape nursing care, there was a report that some people see it as companionship and others see it as a wake-up call (Bridge Michigan/USA). The numerical value of the effect is not in the headline. - An initiative in which Maltese elderly home residents receive training on how to use AI (MaltaToday/Malta). There is no mention of the scale or results of the training.

Digital treatment/regulation

- US FDA officials acknowledged that generative AI-enabled tools need to be evaluated like doctors (MedCity News/US). - US FDA and UK MHRA officials consider a streamlined regulatory framework for generative AI (RAPS/US/UK). It is unclear from the headline whether official guidelines are yet to be issued. - EssilorLuxottica's AI glasses reportedly face regulatory scrutiny despite market success (PYMNTS) The content of the regulations is limited from the headline. - 510(k) notification for electrocardiogram AI (US) was reported as breaking news (MobiHealthNews).

Workplace health

It is not possible to confirm from the headline the entity conducting the survey or the scale of the survey. There is no mention of the system in the heading.

Japanese movements

- Shirakawa City (Fukushima Prefecture) has launched an "AI Consultation Desk" in full swing, responding to a wide range of consultations such as health and childcare (Fukushima Minyu Shimbun/Municipality). The details of the response scope and system are limited from the headline. - MURO launches AI x precision nutrition recipe service (PR TIMES/Company). - OpenAI's Singhal (as shown in the headline) said that 300 million people a week ask ChatGPT questions about their health, but expressed a "I shouldn't be your doctor" attitude (reported via BigGo Finance). - NTL Healthcare's cervical cancer screening AI is now on-premises. However, it was reported that ensuring security is still up to each clinic (remio/company). - Korean medical AI has entered overseas public medical examinations, such as breast cancer examinations in Malta and lung cancer examinations in Australia (reported by Chosun Ilbo/Korean media. There are no headlines that directly refer to Japan).

Remarks from VIPs

- OpenAI's Mr. Singhal (headline notation) said that while 300 million people a week ask questions about health on ChatGPT, he believes that AI "should not become a doctor." - The author of Sapiens warned that "AI's greatest danger is not killer robots but collective dementia" (Business Today). The detailed context of the statement is limited from the headline. - A US FDA official (whose name is not listed in the headline) acknowledged that generative AI-enabled tools need to be evaluated in the same way as doctors. - Jean Bourbeau, MD explained AI and new technologies in COPD care (HCPLive).

AI video/commentary

No applicable information

Additional notes (points to note): This report was created using the information that can be obtained from the headings. For many items, research design, sample size, and effect size were not stated in the headings, and in those cases, we clearly indicated "not stated." Judgments regarding physical condition and symptoms should be made based on consultation with a medical professional, and this report does not include advice for individuals.